These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 736033)

  • 1. Effects of triiodothyronine on the anemia of chronic renal failure.
    Ferrer J; Diez-Ewald M; García R; Rubio L; Rodríguez-Iturbe B
    Am J Hematol; 1978; 5(2):139-43. PubMed ID: 736033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of triiodothyronine replacement on the anemia of chronic renal failure.
    Anagnostou A; Miller M; Westenfelder C; Clemons G; Baranowski R
    Exp Hematol; 1988 Feb; 16(2):159-62. PubMed ID: 3338512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietic effects of triiodothyronine on the anemia of renal failure in rats: comparative studies with testosterone and erythropoietin.
    Malgor LA; Barrios L; de Albarenque ME; Verges E; de Markowsky EE; Montiel E; Mussin SM
    Exp Hematol; 1986 May; 14(4):250-6. PubMed ID: 3699108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum reverse triiodothyronine (3,3',5'-L-triiodothyronine) in chronic renal failure.
    Kosowicz J; Malczewska B; Czekalski S
    Nephron; 1980; 26(2):85-9. PubMed ID: 7412964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of erythropoietin on anemia of peritoneally dialyzed anephric rats.
    Van Stone JC; Max P
    Kidney Int; 1979 Apr; 15(4):370-5. PubMed ID: 513495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of body iron status and uremia severity to anemia in patients with advanced chronic renal failure.
    Ifudu O; Dawood M; Friedman EA
    Nephron; 1997; 77(3):315-8. PubMed ID: 9375826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of erythropoietin treatment on thyroid dysfunction in hemodialysis patients with renal anemia.
    Tomoda F; Takata M; Izumino K; Oh-hashi S; Ueno H; Iida H
    Nephron; 1994; 66(3):307-11. PubMed ID: 8190183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J; Mayer G; Legenstein E; Heinz-Peer G; Leitha T; Hörl WH; Kovarik J
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of histidine supplementation to improve anemia in chronic dialysis patients.
    Reeves RD; Barbour GL; Robertson CS; Crumb CK
    Am J Clin Nutr; 1977 Apr; 30(4):579-81. PubMed ID: 851087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of the anemia of chronic renal failure with subcutaneous recombinant human erythropoietin.
    Watson AJ; Gimenez LF; Cotton S; Walser M; Spivak JL
    Am J Med; 1990 Oct; 89(4):432-5. PubMed ID: 2220877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose intravenous ascorbic acid for erythropoietin-hyporesponsive anemia in diabetic hemodialysis patients with iron overload.
    Lin CL; Hsu PY; Yang HY; Huang CC
    Ren Fail; 2003 May; 25(3):445-53. PubMed ID: 12803508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.
    Silverberg DS; Blum M; Agbaria Z; Deutsch V; Irony M; Schwartz D; Baruch R; Yachnin T; Steinbruch S; Iaina A
    Clin Nephrol; 2001 Mar; 55(3):212-9. PubMed ID: 11316241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Single weekly dose of recombinant erythropoietin in children with chronic renal insufficiency].
    Guízar JM; Gutiérrez MJ; Sánchez G; Kornhauser C
    Rev Invest Clin; 1996; 48(3):173-7. PubMed ID: 8966377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of serum thyrotropin levels using sensitive immunoradiometricassays in patients with chronic renal failure: alterations suggesting an intact pituitary thyroid axis.
    Joseph LJ; Desai KB; Mehta HJ; Mehta MN; Almeida AF; Acharya VN; Samuel AM
    Thyroidology; 1993 Aug; 5(2):35-9. PubMed ID: 7522529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematologic features of chronic renal failure associated with spinal cord injury.
    Vaziri ND; Byrne C; Mirahmadi MK; Golji H; Nikakhtar B; Alday B; Gordon S
    Artif Organs; 1982 Feb; 6(1):69-72. PubMed ID: 7073527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure.
    Hotta T; Ogawa H; Saito A; Ito A
    Int J Hematol; 1991 Jun; 54(3):195-200. PubMed ID: 1747454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of renal anemia.
    Peco-Antic A
    Turk J Pediatr; 2005; 47 Suppl():19-27. PubMed ID: 15884663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial hyperthyroidism due to inappropriate thyrotropin secretion successfully treated with triiodothyronine.
    Rösler A; Litvin Y; Hage C; Gross J; Cerasi E
    J Clin Endocrinol Metab; 1982 Jan; 54(1):76-82. PubMed ID: 6798060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.